Expert Pitch

Experts available to comment on telecommuting's impact on business, shareholders, and protections for employees who can't work remotely

Indiana University
16-Mar-2020 5:05 PM EDT, by Indiana University

Companies may be closing their doors, but their employees are still working. What happens to productivity and performance when employees trade face-to-face interactions with instant messages and virtual meetings? How can employers continue engaging with employees and protect those who can't work from home? Experts from Indiana University are available to comment on these issues.

Having employees working at home can boost productivity, but it also can increase feelings of isolation

Recognizable companies including Google, Twitter and Eli Lilly all are encouraging their employees to work at home to prevent spread of the coronavirus. Research on the benefits and drawbacks of “working from home is still in its infancy, but researchers have generally found that telecommuting can function as a double-edged sword, said Erik Gonzalez-Mulé, assistant professor of organizational behavior and human resources at the Indiana University Kelley School of Business.

"On the one hand, telecommuting can increase productivity because it enhances employees’ feelings of control and autonomy," Gonzalez-Mulé said. "On the other hand, recent studies show that telecommuting can increase feelings of isolation. This is because telecommuting workers have significantly less face-to-face contact with their manager and colleagues, which can lead telecommuters to feel alone and socially disconnected."

Holding meetings online may reduce costs for investors, but it could also allow corporations to avoid scrutiny

Amid decisions to cancel or postpone large gatherings and events due to COVID-19, some corporations – including Starbucks and Qualcomm -- are choosing to move their annual shareholder meetings online. Many public interest advocates fear that this trend could become permanent at companies hoping to avoid scrutiny. Matthew Josefy, an assistant professor of strategic management and entrepreneurship who has studied the issue, said it’s unclear whether virtual meetings should be classified as an emerging habit of well-governed or poorly governed firms.

“On the one hand, moving meetings online technically reduces the cost for investors to monitor the company, as they no longer need to travel to attend. “On the other hand, going online severely limits the opportunity for shareholders’ to gain unfiltered access to management.

Matthew Josefy can be reached by contacting George Vlahakis at vlahakis@iu.edu or 812-855-0846.

Businesses can protect employees don't have paid sick leave or can't work remotely

 About 25 percent of working people in the United States don’t have paid sick leave. So how do you handle an employee who is not feeling well, especially if you run a business where people can’t work from home? Elizabeth Malatestinic, Indiana University Kelley School of Business senior lecturer in human resources, can discuss how you can protect those employees. Malatestinic can also discuss keeping people engaged when they work at home. It can be hard for some – Some love it, and others don’t. They may feel distanced or isolated. How do you work to combat that?




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
2.60367